Edition:
United States

Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

3.50DKK
20 Jul 2017
Change (% chg)

kr.0.00 (+0.00%)
Prev Close
kr.3.50
Open
kr.3.45
Day's High
kr.3.51
Day's Low
kr.3.45
Volume
7,375
Avg. Vol
28,653
52-wk High
kr.4.49
52-wk Low
kr.2.20

NEUR.CO

Chart for NEUR.CO

About

Neurosearch A/S (NEUR) is Denmark-based biopharmaceutical company. It specializes in the research, development and sale of drug candidates. The Company’s portfolio comprises three products: Tesofensine, a drug used in obesity, which works as a monoamine reuptake inhibitor (MRI); Seridopidine, which is applied in central nervous... (more)
No analyst recommendations are available for NEUR.CO.

Overall

Beta: 0.12
Market Cap(Mil.): kr.85.94
Shares Outstanding(Mil.): 24.55
Dividend: --
Yield (%): --

Financials

  NEUR.CO Industry Sector
P/E (TTM): 3.98 212.65 15.78
EPS (TTM): 0.88 -- --
ROI: 30.07 -7.61 -8.29
ROE: 30.07 -9.04 -7.91

BRIEF-Neurosearch FY operating loss flat at DKK 6.3 million

* Fy operating loss 6.3 million Danish crowns ($897,550.97) versus loss 6.5 million crowns year ago

Feb 24 2017

Earnings vs. Estimates

No consensus analysis data available.